![Rabeprazole Capsules - Rabeprazole Sodium Ip 20 Mg [Enteric Coated], Aceclofenac Ip 200 Mg [Sr] , Domperidone 30 Mg [Sustained Release], Itopride Hcl 150 Mg [Sustained Release], Levosulpiride 75 Mg [Sustained Release]](https://cpimg.tistatic.com/09180174/b/4/Rabeprazole-Capsules.jpg)
![Rabeprazole Capsules - Rabeprazole Sodium Ip 20 Mg [Enteric Coated], Aceclofenac Ip 200 Mg [Sr] , Domperidone 30 Mg [Sustained Release], Itopride Hcl 150 Mg [Sustained Release], Levosulpiride 75 Mg [Sustained Release]](https://cpimg.tistatic.com/9180175/b/4/rabeprazole-capsules.jpg)
![Rabeprazole Capsules - Rabeprazole Sodium Ip 20 Mg [Enteric Coated], Aceclofenac Ip 200 Mg [Sr] , Domperidone 30 Mg [Sustained Release], Itopride Hcl 150 Mg [Sustained Release], Levosulpiride 75 Mg [Sustained Release]](https://cpimg.tistatic.com/9180176/b/4/rabeprazole-capsules.jpg)
![Rabeprazole Capsules - Rabeprazole Sodium Ip 20 Mg [Enteric Coated], Aceclofenac Ip 200 Mg [Sr] , Domperidone 30 Mg [Sustained Release], Itopride Hcl 150 Mg [Sustained Release], Levosulpiride 75 Mg [Sustained Release]](https://cpimg.tistatic.com/9180177/b/4/rabeprazole-capsules.jpeg)
![Rabeprazole Capsules - Rabeprazole Sodium Ip 20 Mg [Enteric Coated], Aceclofenac Ip 200 Mg [Sr] , Domperidone 30 Mg [Sustained Release], Itopride Hcl 150 Mg [Sustained Release], Levosulpiride 75 Mg [Sustained Release]](https://cpimg.tistatic.com/09180174/b/4/Rabeprazole-Capsules.jpg)
Rabeprazole Capsules - Rabeprazole Sodium Ip 20 Mg [Enteric Coated], Aceclofenac Ip 200 Mg [Sr] , Domperidone 30 Mg [Sustained Release], Itopride Hcl 150 Mg [Sustained Release], Levosulpiride 75 Mg [Sustained Release]
Price: 236.00 INR / Box
Get Latest Price
Minimum Order Quantity :
10000 Box
Brand Name :
Rabejohn
In Stock
Product Specifications
| Indication | Treatment of gastroesophageal reflux disease, peptic ulcer, Zollinger-Ellison syndrome |
| Dosage Form | Capsule |
| Origin of Medicine | Allopathic |
| Pacakaging (Quantity Per Box) | 100 capsules/box |
| Salt Composition | Rabeprazole Sodium |
| Drug Type | Other, Proton Pump Inhibitor |
| Ingredients | Rabeprazole Sodium |
| Physical Form | Other, Capsule |
| Function | Other, Reduces gastric acid secretion |
| Recommended For | Gastric Ulcers, Acid Reflux, GERD |
| Dosage | As directed by physician |
| Dosage Guidelines | Take before meals |
| Suitable For | Adults |
| Quantity | 10x10 capsules per box |
| Storage Instructions | Store in a cool, dry place; protect from light |
| FOB Port | MUMBAI |
| Payment Terms | Cash Advance (CA), Cash in Advance (CID), Cheque, Western Union |
| Supply Ability | 1000 Per Day |
| Delivery Time | 01 Week |
| Sample Available | Yes |
| Sample Policy | Free samples available with shipping and taxes paid by the buyer |
| Packaging Details | 10X10CAP |
| Main Export Market(s) | Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa |
| Certifications | WHO-GMP |
Product Overview
Key Features
"Rabeprazole Sodium IP 20 Mg [Enteric Coated] + Domperidone
30 Mg [Sustained Release]"
"Rabeprazole Sodium IP 20 Mg [Enteric Coated] + Itopride Hcl
150 Mg [Sustained Release]"
"Rabeprazole Sodium IP 20 Mg [Enteric Coated] + Levosulpiride
75 Mg [Sustained Release]"
Company Details
This is to introduce ourselves as a professionally managed fast growing Pharmaceutical Company having more than Five Years of Manufacturing and Marketing experience. We are based at Mumbai in the State of Maharashtra. The Company has been accredited with ISO-9001:2008 and manufactures pharmaceutical formulations as per the guidelines of WHO. It is a (GMP Certified) Unit with total quality management and In-house Testing Laboratory. Our success is the result of focusing on our clients top priorities such as quality products, on-time delivery, competitive rates and unparalleled responsiveness. Johnlee manufactures more than 400 plus Pharmaceutical Formulation Products in the form of Tablets, Capsules, Dry syrup, Liquid Orals and Sustained Release Preparations. It is the Company constant and Company will also increasingly focus in high growth potential segments like Vaccines and Biogenetics. These new areas will add significant depth to the existing product pipeline. The proteasome has been validated as an important clinical target in cancer, and Johnlee Pharmaceuticals Pvt. Ltd. is developing next-generation proteasome inhibitors with a high degree of selectivity, with the goal of increasing therapeutic efficacy and reducing side effects.
Business Type
Exporter, Manufacturer, Supplier
Employee Count
20
Establishment
2005
Working Days
Monday To Saturday
GST NO
27AGKPJ8183H1ZY
Payment Mode
Cash Advance (CA)
Related Products
Explore Related Categories
More Products From This Seller
Seller Details
GST - 27AGKPJ8183H1ZY
Mumbai, Maharashtra
Director
Mr Vikram K Jain
Members since
12 Years
Address
Office No.22 to 25, 2nd Floor, 72/78, Chapsey Building, Ladwadi, Shamaldas Gandhi Marg, Princess Street, Mumbai, Maharashtra, 400002, India
rabeprazole domperidone capsules in Mumbai
Report incorrect details































